Comments

Pasithea Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Pasithea Therapeutics (KTTAW) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KTTAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Pasithea Therapeutics (KTTAW) Forecast

News Earnings Pasithea Therapeutics (KTTAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Pasithea Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KTTAW | Benzinga

Explore Pasithea Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KTTAW.

Open	-
Close	-
Volume / Avg.	0 / 61.61K
Day Range	- - -
52 Wk Range	0.01 - 0.10
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	2.8

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 61.61K
Day Range	- - -
52 Wk Range	0.01 - 0.10
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	2.8

About Pasithea Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pasithea Therapeutics (KTTAW) stock?

You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTAW) through any online brokerage.

View our list of the best stock brokerages

Who are Pasithea Therapeutics (KTTAW) competitors?

Other companies in Pasithea Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Pasithea Therapeutics (KTTAW) stock?

There is no analysis for Pasithea Therapeutics to provide a consensus price target.

What is the current price for Pasithea Therapeutics (KTTAW)?

The stock price for Pasithea Therapeutics (NASDAQ: KTTAW) is $0.0218 last updated May 14, 2025 at 7:43 AM EDT.

Does Pasithea Therapeutics (KTTAW) pay a dividend?

There are no upcoming dividends for Pasithea Therapeutics.

When is Pasithea Therapeutics (NASDAQ:KTTAW) reporting earnings?

Pasithea Therapeutics does not have any upcoming earnings scheduled.

Is Pasithea Therapeutics (KTTAW) going to split?

There is no upcoming split for Pasithea Therapeutics.

What sector and industry does Pasithea Therapeutics (KTTAW) operate in?

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.